Home Page

University of Washington Division of Neuro-Oncology

Clinical Research Studies

Welcome to the Neuro-Oncology clinical research study website. Neuro-Oncology is a division in the department of Neurology. We are experts in the diagnosis and treatment of brain and spinal cord cancers.

To learn more about clinical research studies click here.

The Neuro-Oncology team is dedicated to providing state-of-the art, patient-focused care.

Below is a list of clinical trials for patients with brain cancers. Click on the title of the study to learn more details.

A phase II trial of PTK-787 in recurrent or progressive meningiomas.
Contact:
· Sandra K Johnston, PhD, RN at (206) 288-6365

A Phase I/II Trial of Temozolomide, Motexafin Gadolinium, and 60 Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme.

Contact Information

Marge Koe, BS, CCRP at (206) 598-4127
Sandra K Johnston, PhD, RN at (206) 288-6365

To learn more about current clinical research studies, feel free to call:

Sandra K Johnston, PhD, RN at (206) 288-6365

University of Washington Division of Neuro-Oncology Clinical Research Studies

Below are Links to Our Departments University of Washington Department of Neurology University of Washington Department of Neurosurgery Seattle Cancer Care Alliance-Neuro-Oncology Links to Learn More About Brain and Spine Cancers Seattle Cancer Care Alliance-Neuro-Oncology Treatment of brain and spinal cord cancers Latest News from the University of Washington Neuro-oncology/Neurosurgery Team Upcoming Event: Program for people with brain tumors and those that care about them Research Team Members Access	Neuro-Oncology Clinical Research Studies Welcome to the Neuro-Oncology clinical research study website. Neuro-Oncology is a division in the department of Neurology. We are experts in the diagnosis and treatment of brain and spinal cord cancers. To learn more about clinical research studies click here. The Neuro-Oncology team is dedicated to providing state-of-the art, patient-focused care. Below is a list of clinical trials for patients with brain cancers. Click on the title of the study to learn more details. Meningioma Research Study A phase II trial of PTK-787 in recurrent or progressive meningiomas. Contact:* · Sandra K Johnston, PhD, RN at (206) 288-6365 Recurrent Brain Tumor Study A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (anaplastic gliomas and glioblastoma). Contact: · Sandra K Johnston, PhD, RN at (206) 288-6365* Recurrent Brain Tumor Study A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [AZD2171, RECENTIN™] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone. Contact: · Sandra K Johnston, PhD, RN at (206) 288-6365* Low-Grade Glioma Research Study A Phase II Study Of a Temozolomide-Based Chemoradiotherapy Regimen for High Risk Low-Grade Gliomas (RTOG 0424)* Contact: Marge Koe, BS, CCRP at (206) 598-4127 Glioblastoma Research Study Phase I-II Study of Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas Contact: Jennifer Adair at (206) 667-7110 Glioblastoma Research Study A Phase II/III Randomized Study of CDX-110 with Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme. Contact: Robyn Haaf, RN, BS at (206) 667-5974 Glioblastoma Study (RTOG 0513) A Phase I/II Trial of Temozolomide, Motexafin Gadolinium, and 60 Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme. Contact Information Marge Koe, BS, CCRP at (206) 598-4127 Sandra K Johnston, PhD, RN at (206) 288-6365 Study Contact Information To learn more about current clinical research studies, feel free to call: Sandra K Johnston, PhD, RN at (206) 288-6365 Contact Web Manager Sandra Johnston, PhD, RN